Smartsight Correction Of Moderate To High Astigmatism Treatments With The Schwind Atos
Published 2024 - 42nd Congress of the ESCRS
Reference: PO1167 | Type: Free paper | DOI: 10.82333/j1p8-5k28
Authors: Maja Bohac* 1 , Ivan Gabric 1 , Samuel Arba Mosquera 2
1Cornea and Refractive Surgery,Specialty Eye Hospital Svjetlost,Zagreb,Croatia, 2Schwind Eye Tech Solutions,Kleinostheim,Germany
Purpose
To evaluate moderate to high astigmatism corrections (above 2 diopters (D) of a cylinder) on the outcomes of SmartSight lenticule extraction for myopic astigmatism with a new femtosecond laser system.
Setting
Eye Clinic Svjetlost, Zagreb, Croatia
Methods
33 eyes of 24 patients consecutively treated for myopic astigmatism with astigmatism magnitude over 2 D were evaluated at the 3-month follow-up. The mean age of the patients was 30,65±6.91 years with a mean spherical equivalent of -5.07±2.20 D and a mean magnitude of refractive astigmatism of 2.74±0.71 D.
Results
At 3 months, manifest astigmatism was 0.35±0.30D; uncorrected and corrected visual acuities (UDVA and CDVA, respectively) were 0.0±0.1logMAR; differences between postop UDVA and preop CDVA along with change in CDVA were +0.5±0.8lines better the preoperatively (p<0.004).
Conclusions
Lenticule extraction treatment using SmartSight is safe and efficacious at 3-months. Findings suggest that moderate to high astigmatism improves after SmartSight lenticule extraction in the treatment of myopic astigmatism.